Effects of Bee Venom Acupuncture on the Rehabilitation and Quality of Life in Rheumatoid Arthritis Patients

Objective: To evaluate the effects of bee venom acupuncture(BVA) on the rehabilitation and quality of life in rheumatoid arthritis(RA) patients Methods: Patients with RA were treated with the BVA therapy twice a week for 3 months. Tender joint counts, swollen joint counts, morning stiffness, Erythrocyte Sedimentation Rate(ESR), C-reactive protein(CRP), patient global assessment, physician global assessment, Korean health assessment questionnaire(KHAQ) were estimated and analyzed before and after BVA therapy. Results: Tender joint counts, swollen joint counts, morning stiffness showed significant decrease after BVA therapy. But, as acute inflammatory reactants, ESR showed no significant difference and CRP showed significant increase after BVA therapy. Patient global assessment, physician global assessment, and KHAQ index showed significant improvement after BVA therapy. Conclusions: BVA therapy can improve rehabilitation and health-related quality of life in RA patients as well as clinical symptoms and signs. Further study is required in more population with large scale including acute inflammatory reaction of BVA therapy..

Medienart:

E-Artikel

Erscheinungsjahr:

2002

Erschienen:

2002

Enthalten in:

Zur Gesamtaufnahme - volume:5

Enthalten in:

Journal of Pharmacopuncture - 5(2002), 2, Seite 63-70

Sprache:

Englisch ; Koreanisch

Beteiligte Personen:

Lee Sang-Hoon [VerfasserIn]
Lee Hyun-Jong [VerfasserIn]
Park Sang-Min [VerfasserIn]
Kim Su-Young [VerfasserIn]
Park Jae-Kyung [VerfasserIn]
Hong Seung-Jae [VerfasserIn]
Yang Hyung-In [VerfasserIn]
Choi Do-Young [VerfasserIn]
Kim Keon-Sik [VerfasserIn]
Lee Doo-Ik [VerfasserIn]
Lee Yun-Ho [VerfasserIn]
Lee Jae-Dong [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
dx.doi.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Bee venom acupuncture
HAQ
Medicine
Miscellaneous systems and treatments
Quality of life
R
Rheumatoid arthritis
Therapeutics. Pharmacology

doi:

10.3831/KPI.2002.5.2.063

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ045641587